Pfizer Must Pay Kaiser Cost-Difference Of Cheaper Drugs Under Neurontin Marketing Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
Judge Patti Saris finds Pfizer fraudulently marketed its anti-epileptic in violation of California law and orders the company to pay Kaiser $95 million.